Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Cardiothorac Surg. 2011 Sep;40(3):761-3. doi: 10.1016/j.ejcts.2010.12.063. Epub 2011 Feb 21.

A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™.

Author information

1
Department of Cardiac Surgery, Heartcenter, University of Leipzig, Leipzig, Germany. Kempfert@web.de

Abstract

Transapical aortic valve implantation (TA-AVI) has evolved as a routine procedure to treat selected high-risk elderly patients. In the vast majority, the balloon-expandable SAPIEN™ prosthesis has been used for TA-AVI. The new JenaValve™ prosthesis is designed for antegrade transapical implantation and consists of a self-expandable Nitinol™ stent with a porcine tissue-prosthesis mounted on a sheath-less delivery catheter. Key features of the device are three 'positioning feelers' facilitating intuitive 'self-positioning' valve implantation. The JenaValve™ concept results in a subcoronary valve position with an anatomically correct valve rotation relying on axial in addition to radial fixation by the three Nitinol™ 'feelers' embracing the native valve leaflets. Here, we report the successful first-in-man implantation in an elderly high-risk patient using a transapical off-pump approach. The JenaValve™ demonstrated proof of concept and a good functional result immediately after deployment and at 12-months' follow-up.

PMID:
21334914
DOI:
10.1016/j.ejcts.2010.12.063
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center